Clinical and economic considerations in the use of third-generation oral cephalosporins.

A number of oral third-generation cephalosporins (cefixime, cefetamet pivoxil, ceftibuten and cefpodoxime proxetil) have been widely trial led and are becoming available. In addition, cefdinir may also be marketed.